APO Research
Talk to an analyst

APO RESEARCH · REPORT

Niemann-Pick Disease Type C (NPC)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Niemann-Pick Disease Type C (NPC) Industry Growth and Trends Forecast to 2032

19 December 202577 pages

Choose your research edition.

Industry ResearchNiemann-Pick Disease Type C (NPC) Industry Research Report 2026111 pages · $2,950 USDIndustry Growth & TrendsGlobal Niemann-Pick Disease Type C (NPC) Industry Growth and Trends Forecast to 203277 pages · $3,450 USDMarket StructureGlobal Niemann-Pick Disease Type C (NPC) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Niemann-Pick Disease Type C (NPC) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Niemann-Pick Disease Type C (NPC) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Niemann-Pick Disease Type C (NPC) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Niemann-Pick Disease Type C (NPC) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Niemann-Pick Disease Type C (NPC) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Niemann-Pick Disease Type C (NPC) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Niemann-Pick Disease Type C (NPC) include Cyclo Therapeutics, Orphazyme A/S and Johnson & Johnson, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Niemann-Pick Disease Type C (NPC) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Niemann-Pick Disease Type C (NPC) market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Niemann-Pick Disease Type C (NPC) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Niemann-Pick Disease Type C (NPC).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Niemann-Pick Disease Type C (NPC) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Niemann-Pick Disease Type C (NPC) Market by Company

Cyclo Therapeutics

Orphazyme A/S

Johnson & Johnson

Niemann-Pick Disease Type C (NPC) Segment by Type

Trappsol Cyclo

Arimoclomol

Miglustat (Zavesca)

Niemann-Pick Disease Type C (NPC) Segment by Application

Hospital Pharmacies

Retail Pharmacies

Niemann-Pick Disease Type C (NPC) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Niemann-Pick Disease Type C (NPC) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Niemann-Pick Disease Type C (NPC) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Niemann-Pick Disease Type C (NPC).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Niemann-Pick Disease Type C (NPC) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Niemann-Pick Disease Type C (NPC) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Trappsol Cyclo Table 2. Major Company of Arimoclomol Table 3. Major Company of Miglustat (Zavesca) Table 4. Global Niemann-Pick Disease Type C (NPC) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (K Units) Table 6. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type (2021-2026) Table 9. Global Niemann-Pick Disease Type C (NPC) Price by Type (2021-2026) & (US$/Unit) Table 10. Global Niemann-Pick Disease Type C (NPC) Sales by Type (2027-2032) & (K Units) Table 11. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Niemann-Pick Disease Type C (NPC) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type (2027-2032) Table 14. Global Niemann-Pick Disease Type C (NPC) Price by Type (2027-2032) & (US$/Unit) Table 15. North America Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (K Units) Table 16. North America Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (K Units) Table 18. Europe Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (K Units) Table 22. Latin America Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Type (2021-2026) & (US$ Million) Table 25. Niemann-Pick Disease Type C (NPC) Industry Trends Table 26. Niemann-Pick Disease Type C (NPC) Industry Drivers Table 27. Niemann-Pick Disease Type C (NPC) Industry Opportunities and Challenges Table 28. Niemann-Pick Disease Type C (NPC) Industry Restraints Table 29. Global Niemann-Pick Disease Type C (NPC) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Niemann-Pick Disease Type C (NPC) Revenue Market Share by Company (2021-2026) Table 31. Global Niemann-Pick Disease Type C (NPC) Sales by Company (2021-2026) & (K Units) Table 32. Global Niemann-Pick Disease Type C (NPC) Sales Share by Company (2021-2026) Table 33. Global Niemann-Pick Disease Type C (NPC) Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Niemann-Pick Disease Type C (NPC) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Niemann-Pick Disease Type C (NPC) Major Company Production Sites and Headquarters Table 36. Global Niemann-Pick Disease Type C (NPC) Company, Product Type & Application Table 37. Global Niemann-Pick Disease Type C (NPC) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Niemann-Pick Disease Type C (NPC) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Niemann-Pick Disease Type C (NPC) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Niemann-Pick Disease Type C (NPC) Sales by Region (2021-2026) & (K Units) Table 42. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Niemann-Pick Disease Type C (NPC) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Region (2021-2026) Table 45. Global Niemann-Pick Disease Type C (NPC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Niemann-Pick Disease Type C (NPC) Sales by Region (2027-2032) & (K Units) Table 47. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Niemann-Pick Disease Type C (NPC) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Region (2027-2032) Table 50. Global Niemann-Pick Disease Type C (NPC) Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Niemann-Pick Disease Type C (NPC) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (K Units) Table 53. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application (2021-2026) Table 56. Global Niemann-Pick Disease Type C (NPC) Price by Application (2021-2026) & (US$/Unit) Table 57. Global Niemann-Pick Disease Type C (NPC) Sales by Application (2027-2032) & (K Units) Table 58. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Niemann-Pick Disease Type C (NPC) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application (2027-2032) Table 61. Global Niemann-Pick Disease Type C (NPC) Price by Application (2027-2032) & (US$/Unit) Table 62. North America Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (K Units) Table 63. North America Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (K Units) Table 65. Europe Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (K Units) Table 69. Latin America Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Application (2021-2026) & (US$ Million) Table 72. Cyclo Therapeutics Company Information Table 73. Cyclo Therapeutics Business Overview Table 74. Cyclo Therapeutics Niemann-Pick Disease Type C (NPC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Cyclo Therapeutics Niemann-Pick Disease Type C (NPC) Product Portfolio Table 76. Cyclo Therapeutics Recent Development Table 77. Orphazyme A/S Company Information Table 78. Orphazyme A/S Business Overview Table 79. Orphazyme A/S Niemann-Pick Disease Type C (NPC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Orphazyme A/S Niemann-Pick Disease Type C (NPC) Product Portfolio Table 81. Orphazyme A/S Recent Development Table 82. Johnson & Johnson Company Information Table 83. Johnson & Johnson Business Overview Table 84. Johnson & Johnson Niemann-Pick Disease Type C (NPC) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Johnson & Johnson Niemann-Pick Disease Type C (NPC) Product Portfolio Table 86. Johnson & Johnson Recent Development Table 87. North America Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 88. North America Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026) & (K Units) Table 89. North America Niemann-Pick Disease Type C (NPC) Sales Market Share by Country (2021-2026) Table 90. North America Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032) & (K Units) Table 91. North America Niemann-Pick Disease Type C (NPC) Sales Market Share Forecast by Country (2027-2032) Table 92. North America Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 93. North America Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026) & (US$ Million) Table 94. North America Niemann-Pick Disease Type C (NPC) Market Share by Country (2021-2026) Table 95. North America Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 96. North America Niemann-Pick Disease Type C (NPC) Market Share Forecast by Country (2027-2032) Table 97. Europe Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 98. Europe Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026) & (K Units) Table 99. Europe Niemann-Pick Disease Type C (NPC) Sales Market Share by Country (2021-2026) Table 100. Europe Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032) & (K Units) Table 101. Europe Niemann-Pick Disease Type C (NPC) Sales Market Share Forecast by Country (2027-2032) Table 102. Europe Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 103. Europe Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026) & (US$ Million) Table 104. Europe Niemann-Pick Disease Type C (NPC) Market Share by Country (2021-2026) Table 105. Europe Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 106. Europe Niemann-Pick Disease Type C (NPC) Market Share Forecast by Country (2027-2032) Table 107. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 108. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026) & (K Units) Table 109. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Market Share by Country (2021-2026) Table 110. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032) & (K Units) Table 111. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026) & (US$ Million) Table 114. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Share by Country (2021-2026) Table 115. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 116. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Share Forecast by Country (2027-2032) Table 117. Latin America Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 118. Latin America Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026) & (K Units) Table 119. Latin America Niemann-Pick Disease Type C (NPC) Sales Market Share by Country (2021-2026) Table 120. Latin America Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032) & (K Units) Table 121. Latin America Niemann-Pick Disease Type C (NPC) Sales Market Share Forecast by Country (2027-2032) Table 122. Latin America Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 123. Latin America Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026) & (US$ Million) Table 124. Latin America Niemann-Pick Disease Type C (NPC) Market Share by Country (2021-2026) Table 125. Latin America Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 126. Latin America Niemann-Pick Disease Type C (NPC) Market Share Forecast by Country (2027-2032) Table 127. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 128. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026) & (K Units) Table 129. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Market Share by Country (2021-2026) Table 130. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032) & (K Units) Table 131. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026) & (US$ Million) Table 134. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Share by Country (2021-2026) Table 135. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Share Forecast by Country (2027-2032) Table 137. Key Raw Materials Table 138. Raw Materials Key Suppliers Table 139. Niemann-Pick Disease Type C (NPC) Distributors List Table 140. Niemann-Pick Disease Type C (NPC) Customers List Table 141. Research Programs/Design for This Report Table 142. Authors List of This Report Table 143. Secondary Sources Table 144. Primary Sources List of Figures Figure 1. Niemann-Pick Disease Type C (NPC) Image Figure 2. Global Niemann-Pick Disease Type C (NPC) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Niemann-Pick Disease Type C (NPC) Market Size (2021-2032) & (US$ Million) Figure 4. Global Niemann-Pick Disease Type C (NPC) Sales (2021-2032) & (K Units) Figure 5. Trappsol Cyclo Image Figure 6. Global Trappsol Cyclo Sales YoY Growth (2021-2032) & (K Units) Figure 7. Arimoclomol Image Figure 8. Global Arimoclomol Sales YoY Growth (2021-2032) & (K Units) Figure 9. Miglustat (Zavesca) Image Figure 10. Global Miglustat (Zavesca) Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Niemann-Pick Disease Type C (NPC) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Niemann-Pick Disease Type C (NPC) Market Share by Type 2025 VS 2032 Figure 13. North America Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type in 2025 Figure 14. North America Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type in 2025 Figure 15. Europe Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Niemann-Pick Disease Type C (NPC) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Pharmacies Image Figure 26. Global Hospital Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 27. Retail Pharmacies Image Figure 28. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Niemann-Pick Disease Type C (NPC) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Niemann-Pick Disease Type C (NPC) Market Share by Application 2025 VS 2032 Figure 31. North America Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application in 2025 Figure 32. North America Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application in 2025 Figure 33. Europe Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application in 2025 Figure 34. Europe Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application in 2025 Figure 37. Latin America Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Market Share in Value by Application in 2025 Figure 41. North America Niemann-Pick Disease Type C (NPC) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Niemann-Pick Disease Type C (NPC) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Niemann-Pick Disease Type C (NPC) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Niemann-Pick Disease Type C (NPC) Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Niemann-Pick Disease Type C (NPC) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Niemann-Pick Disease Type C (NPC) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Niemann-Pick Disease Type C (NPC) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Niemann-Pick Disease Type C (NPC) Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Niemann-Pick Disease Type C (NPC) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Niemann-Pick Disease Type C (NPC) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Niemann-Pick Disease Type C (NPC) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Niemann-Pick Disease Type C (NPC) Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Niemann-Pick Disease Type C (NPC) Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Niemann-Pick Disease Type C (NPC) Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Trappsol Cyclo
  • Arimoclomol
  • Miglustat (Zavesca)
Applications
  • Hospital Pharmacies
  • Retail Pharmacies
Companies covered
  • Cyclo Therapeutics
  • Orphazyme A/S
  • Johnson & Johnson

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Niemann-Pick Disease Type C (NPC) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Niemann-Pick Disease Type C (NPC) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Niemann-Pick Disease Type C (NPC) Market by Type
  6. 1.3.1 Trappsol Cyclo
  7. 1.3.2 Arimoclomol
  8. 1.3.3 Miglustat (Zavesca)
  9. 1.4 Global Niemann-Pick Disease Type C (NPC) Market Size by Type
  10. 1.4.1 Global Niemann-Pick Disease Type C (NPC) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Niemann-Pick Disease Type C (NPC) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Niemann-Pick Disease Type C (NPC) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Niemann-Pick Disease Type C (NPC) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Niemann-Pick Disease Type C (NPC) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Niemann-Pick Disease Type C (NPC) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Niemann-Pick Disease Type C (NPC) Industry Trends
  2. 2.2 Niemann-Pick Disease Type C (NPC) Industry Drivers
  3. 2.3 Niemann-Pick Disease Type C (NPC) Industry Opportunities and Challenges
  4. 2.4 Niemann-Pick Disease Type C (NPC) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Niemann-Pick Disease Type C (NPC) Revenue (2021-2026)
  2. 3.2 Global Top Players by Niemann-Pick Disease Type C (NPC) Sales (2021-2026)
  3. 3.3 Global Top Players by Niemann-Pick Disease Type C (NPC) Price (2021-2026)
  4. 3.4 Global Niemann-Pick Disease Type C (NPC) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Niemann-Pick Disease Type C (NPC) Major Company Production Sites & Headquarters
  6. 3.6 Global Niemann-Pick Disease Type C (NPC) Company, Product Type & Application
  7. 3.7 Global Niemann-Pick Disease Type C (NPC) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Niemann-Pick Disease Type C (NPC) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Niemann-Pick Disease Type C (NPC) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Niemann-Pick Disease Type C (NPC) Tier 1, Tier 2, and Tier 3
4 Niemann-Pick Disease Type C (NPC) Regional Status and Outlook
  1. 4.1 Global Niemann-Pick Disease Type C (NPC) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Niemann-Pick Disease Type C (NPC) Historic Market Size by Region
  3. 4.2.1 Global Niemann-Pick Disease Type C (NPC) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Niemann-Pick Disease Type C (NPC) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Niemann-Pick Disease Type C (NPC) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Niemann-Pick Disease Type C (NPC) Forecasted Market Size by Region
  7. 4.3.1 Global Niemann-Pick Disease Type C (NPC) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Niemann-Pick Disease Type C (NPC) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Niemann-Pick Disease Type C (NPC) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Niemann-Pick Disease Type C (NPC) by Application
  1. 5.1 Niemann-Pick Disease Type C (NPC) Market by Application
  2. 5.1.1 Hospital Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.2 Global Niemann-Pick Disease Type C (NPC) Market Size by Application
  5. 5.2.1 Global Niemann-Pick Disease Type C (NPC) Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Niemann-Pick Disease Type C (NPC) Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Niemann-Pick Disease Type C (NPC) Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Niemann-Pick Disease Type C (NPC) Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Niemann-Pick Disease Type C (NPC) Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Niemann-Pick Disease Type C (NPC) Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cyclo Therapeutics
  2. 6.1.1 Cyclo Therapeutics Company Information
  3. 6.1.2 Cyclo Therapeutics Business Overview
  4. 6.1.3 Cyclo Therapeutics Niemann-Pick Disease Type C (NPC) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cyclo Therapeutics Niemann-Pick Disease Type C (NPC) Product Portfolio
  6. 6.1.5 Cyclo Therapeutics Recent Developments
  7. 6.2 Orphazyme A/S
  8. 6.2.1 Orphazyme A/S Company Information
  9. 6.2.2 Orphazyme A/S Business Overview
  10. 6.2.3 Orphazyme A/S Niemann-Pick Disease Type C (NPC) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Orphazyme A/S Niemann-Pick Disease Type C (NPC) Product Portfolio
  12. 6.2.5 Orphazyme A/S Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Niemann-Pick Disease Type C (NPC) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Niemann-Pick Disease Type C (NPC) Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
7 North America by Country
  1. 7.1 North America Niemann-Pick Disease Type C (NPC) Sales by Country
  2. 7.1.1 North America Niemann-Pick Disease Type C (NPC) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026)
  4. 7.1.3 North America Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Niemann-Pick Disease Type C (NPC) Market Size by Country
  6. 7.2.1 North America Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026)
  8. 7.2.3 North America Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Niemann-Pick Disease Type C (NPC) Sales by Country
  2. 8.1.1 Europe Niemann-Pick Disease Type C (NPC) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026)
  4. 8.1.3 Europe Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Niemann-Pick Disease Type C (NPC) Market Size by Country
  6. 8.2.1 Europe Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Country
  2. 9.1.1 Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size by Country
  6. 9.2.1 Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Niemann-Pick Disease Type C (NPC) Sales by Country
  2. 10.1.1 South America Niemann-Pick Disease Type C (NPC) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026)
  4. 10.1.3 South America Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Niemann-Pick Disease Type C (NPC) Market Size by Country
  6. 10.2.1 South America Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026)
  8. 10.2.3 South America Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Country
  2. 11.1.1 Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Niemann-Pick Disease Type C (NPC) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size by Country
  6. 11.2.1 Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Niemann-Pick Disease Type C (NPC) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Niemann-Pick Disease Type C (NPC) Value Chain Analysis
  2. 12.1.1 Niemann-Pick Disease Type C (NPC) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Niemann-Pick Disease Type C (NPC) Production Mode & Process
  7. 12.2 Niemann-Pick Disease Type C (NPC) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Niemann-Pick Disease Type C (NPC) Distributors
  10. 12.2.3 Niemann-Pick Disease Type C (NPC) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst